Literature DB >> 7516357

Cross-reactive antibodies in the serum of balb/c mice immunized with thyroid or eye muscle membranes.

J R Wall1, H Triller, F Chung, M Tsao, A Boucher, P Rodien, A Liberman, N Bernard.   

Abstract

During the course of immunizing balb/c mice with eye muscle (EM) or thyroid (THY) membranes for monoclonal antibody (MCAB) production their sera frequently contain antibodies which react against both EM and THY membranes in enzyme-linked immunosorbent assay (ELISA) and SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. In order to further study this phenomenon we have analyzed sera from 27 balb/c mice, including 10 that were studied serially, and their tissues examined histologically at sacrifice. Following immunization serum and, in some cases, the corresponding MCAB produced by fusion of the mouse spleen cells with a mouse myeloma cell line, were tested for EM and THY cross-reactivity in an ELISA and by immunoblotting. The number of antibodies demonstrated in Western blotting identified as bands of reactivity, and ELISA levels, expressed as optical density--increased with time, each peaking at around 10-12 weeks. THY and EM antibody cross-reactivity was demonstrated in the majority of mice, serum from mice immunized with THY membranes reacting with these membranes as well as with pig EM membranes in both ELISA and immunoblotting and, conversely, sera from mice immunized with pig EM membranes also reacting with THY membranes in the two tests. In Western blotting a variety of THY and EM-reactive antibodies were demonstrated including those directed against a 64 kDa protein, shown to be an important autoantigen in thyroid-associated ophthalmopathy. There was also some cross-reactivity with brain membranes, used as control antigen in both tests and in immunization, although to a lesser degree, but very little to liver and orbital connective tissue membrane.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516357     DOI: 10.1007/BF03347694

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Eye muscle membrane reactive antibodies are not detected in the serum or immunoglobulin fraction of patients with thyroid-associated ophthalmopathy using an ELISA and crude membranes.

Authors:  M Kapusta; M Salvi; H Triller; E Gardini; N Bernard; J R Wall
Journal:  Autoimmunity       Date:  1990       Impact factor: 2.815

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease.

Authors:  Q Dong; M Ludgate; G Vassart
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

4.  Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthalmopathy.

Authors:  A Miller; H Sikorska; M Salvi; J R Wall
Journal:  Acta Endocrinol (Copenh)       Date:  1986-12

5.  A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy.

Authors:  Y Hiromatsu; H Fukazawa; F Guinard; M Salvi; J How; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

6.  Human placental alkaline phosphatase. An improved purification procedure and kinetic studies.

Authors:  T C Chang; S M Huang; T M Huang; G G Chang
Journal:  Eur J Biochem       Date:  1992-10-01

7.  Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy.

Authors:  K Kodama; H Sikorska; P Bandy-Dafoe; R Bayly; J R Wall
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

8.  Muscle and species reactivity of mouse monoclonal antibodies to human eye muscle membrane antigens.

Authors:  B Teboul; H Triller; F Chung; N Bernard; Z G Zhang; J R Wall; M Salvi
Journal:  Clin Immunol Immunopathol       Date:  1991-04

9.  Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.

Authors:  P W Wang; Y Hiromatsu; E Laryea; L Wosu; J How; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

10.  Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.

Authors:  A Ahmann; J R Baker; A P Weetman; L Wartofsky; T B Nutman; K D Burman
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958

View more
  2 in total

Review 1.  Thyroid eye disease.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

2.  Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?

Authors:  J I Kiljanski; K Peele; I Stachura; J Pickeral; C Stolarski; J S Kennerdell; J R Wall
Journal:  J Endocrinol Invest       Date:  1997-11       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.